<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Fetuin-A is an inhibitor of <z:hpo ids='HP_0004934'>vascular calcification</z:hpo> and a mediator of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study evaluated the association of plasma fetuin-A and <z:hpo ids='HP_0004950'>peripheral arterial disease</z:hpo> (PAD) </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 738 individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (mean age 58.7 years, 37.1% female) without known cardiovascular or <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> were included in this cross-sectional analysis </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Subjects with PAD had a significantly lower fetuin-A (264.3 vs. 293.4 ng/dl, P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>In multivariable analysis, a 1-SD decrease in fetuin-A increased the odds of PAD (odds ratio 1.6, P = 0.02) </plain></SENT>
<SENT sid="5" pm="."><plain>Subgroup analysis revealed an increased odds even in subjects with glomerular filtration rate &gt;80 (odds ratio 1.9, P = 0.05) or high-sensitivity C-reactive protein &lt;3 mg/dl (odds ratio 2.7, P = 0.002) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Lower circulating fetuin-A is associated with PAD in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> beyond traditional and novel <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest a potentially unique role for fetuin-A deficiency as a biomarker of PAD in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>